Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

4.6K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Negative Regulator Molecules01:23

Negative Regulator Molecules

35.8K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.8K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Altered expression of MX2 and SAMD4A in PBMCs predicts early treatment responses in HBeAg-positive chronic hepatitis B patients during Peg-IFN-α therapy.

Frontiers in pharmacology·2026
Same author

Face/off: phase-specific modeling of lineage plasticity using near-patient models in genitourinary cancers.

Gene·2026
Same author

Establishment of epidemiological cutoff values against <i>Fonsecaea monophora</i>, an agent of chromoblastomycosis and cerebral phaeohyphomycosis.

Journal of clinical microbiology·2026
Same author

A Cathepsin <i>B</i>-Cleavable Self-Immolative Linker for the Delivery of Hydroxyl-Containing Payloads in Antibody-Drug Conjugates.

Bioconjugate chemistry·2026
Same author

Loss of PDL1 in mesenchymal stromal cells from young-onset MDS-RAEB-1 promotes inflamm-aging through epigenetic dysregulation of H3K9me3.

Stem cells translational medicine·2026
Same author

Trends in the diagnosis of variant bladder cancer: a national retrospective cohort analysis.

Frontiers in oncology·2026

Related Experiment Video

Updated: Sep 4, 2025

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
09:04

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies

Published on: April 22, 2017

9.1K

DRR1 promotes neuroblastoma cell differentiation by regulating CREB expression.

Luping Chen1, Bin Mu2, Yalong Li1

  • 1Department of Physiology, Shenyang Medical College, Shenyang, Liaoning, P.R. China.

Pediatric Research
|July 19, 2022
PubMed
Summary

Downregulating DRR1 inhibits neuroblastoma cell differentiation. The DRR1-CREB axis is crucial for neuroblastoma differentiation and patient outcomes, offering potential therapeutic targets.

More Related Videos

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

1.2K
Ex Utero Electroporation and Organotypic Slice Culture of Mouse Hippocampal Tissue
09:17

Ex Utero Electroporation and Organotypic Slice Culture of Mouse Hippocampal Tissue

Published on: March 4, 2015

9.6K

Related Experiment Videos

Last Updated: Sep 4, 2025

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies
09:04

Analysis of Retinoic Acid-induced Neural Differentiation of Mouse Embryonic Stem Cells in Two and Three-dimensional Embryoid Bodies

Published on: April 22, 2017

9.1K
Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection
11:00

Real-Time Quantitative Measurement of Tumor Cell Migration and Invasion Following Synthetic mRNA Transfection

Published on: June 23, 2023

1.2K
Ex Utero Electroporation and Organotypic Slice Culture of Mouse Hippocampal Tissue
09:17

Ex Utero Electroporation and Organotypic Slice Culture of Mouse Hippocampal Tissue

Published on: March 4, 2015

9.6K

Area of Science:

  • Oncology
  • Molecular Biology
  • Cell Biology

Background:

  • Neuroblastoma is a common infant cancer and childhood extracranial solid tumor.
  • Downregulation of DRR1 was observed in poorly differentiated neuroblastoma cells.
  • The precise role of DRR1 in neuroblastoma pathogenesis was largely unknown.

Purpose of the Study:

  • To investigate the role of DRR1 in neuroblastoma cell differentiation.
  • To identify downstream targets of DRR1 involved in neuroblastoma development.
  • To explore the therapeutic potential of the DRR1-CREB pathway.

Main Methods:

  • Neuroblastoma cells were induced to differentiate, and DRR1 expression was analyzed.
  • CRISPR interference (CRISPRi) and overexpression vectors were used to manipulate DRR1 and CREB levels.
  • Chromatin immunoprecipitation sequencing (ChIP-seq) identified downstream genes of DRR1.
  • Cell differentiation markers, cell cycle distribution, and tumor growth were assessed.

Main Results:

  • DRR1 expression increased upon neuroblastoma cell differentiation.
  • Downregulation of DRR1 impaired neuroblastoma cell differentiation.
  • CREB was identified as a downstream mediator of DRR1's function in differentiation.
  • Overexpression of CREB reversed the inhibitory effects of DRR1 knockdown on differentiation and tumor growth.

Conclusions:

  • The DRR1-CREB axis plays a significant role in modulating neuroblastoma cell differentiation.
  • This pathway is associated with patient prognosis in neuroblastoma.
  • Targeting the DRR1-CREB interaction may offer a novel therapeutic strategy for neuroblastoma.